Publicaciones en las que colabora con José Luis Lanciego Pérez (23)

2012

  1. Loss of parvalbumin-positive neurons from the globus pallidus in animal models of parkinson disease

    Journal of Neuropathology and Experimental Neurology, Vol. 71, Núm. 11, pp. 973-982

2010

  1. Production of highly pure human glycosylated GDNF in a mammalian cell line

    International Journal of Pharmaceutics, Vol. 385, Núm. 1-2, pp. 6-11

2009

  1. Effective GDNF brain delivery using microspheres-A promising strategy for Parkinson's disease

    Journal of Controlled Release, Vol. 135, Núm. 2, pp. 119-126

  2. Interactions between calmodulin, adenosine A2A, and dopamine D2 receptors

    Journal of Biological Chemistry, Vol. 284, Núm. 41, pp. 28058-28068

  3. The search for a role of the caudal intralaminar nuclei in the pathophysiology of Parkinson's disease

    Brain Research Bulletin, Vol. 78, Núm. 2-3, pp. 55-59

2008

  1. Controlled drug delivery to the brain: an overview

    Handbook of particulate drug delivery (American Scientific Publishers), pp. 121 - 142

  2. Expression of vesicular glutamate transporters 1 and 2 in the cells of origin of the rat thalamostriatal pathway

    Journal of Chemical Neuroanatomy, Vol. 35, Núm. 1, pp. 101-107

  3. Sustained release of bioactive glycosylated glial cell-line derived neurotrophic factor from biodegradable polymeric microspheres

    European Journal of Pharmaceutics and Biopharmaceutics, Vol. 69, Núm. 3, pp. 844-851